...
首页> 外文期刊>Clinical nephrology >Arteriovenous fistula using transposed basilic vein in chronic hypotensive hemodialysis patients.
【24h】

Arteriovenous fistula using transposed basilic vein in chronic hypotensive hemodialysis patients.

机译:慢性降血压性血液透析患者使用转置的基底静脉动静脉瘘。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: Chronic hypotension is not uncommon in uremic patients on regular hemodialysis. This subset of patients often requires multiple operations to maintain their vascular access due to frequent thrombosis and occlusion of the arteriovenous fistula. Our aims was to assess whether surgical intervention with the brachial artery-transposed basilic vein fistula is effective in chronic hypotensive hemodialysis patients. MATERIALS AND METHODS: Fifty-four hemodialysis patients with chronic hypotension were enrolled in this study. Most ofthem were referred from local hospitals. They were 23 men and 31 women. The brachial artery-transposed basilic vein arteriovenous fistula was performed in a period of 46 months at the teaching hospital. Primary patency was defined as the length of time from the fistula creation until the development of thrombosis or a complication that required operative revision ofthe fistula. Secondary patency was defined by whether the fistula could be salvaged by revision such that blood flow was maintained. RESULTS: There was no technical failure and none of these patients died due to the surgical operation. The primary patency rate was 89.80% at 1 year, 73.08% at 2 years, and 64.710% at 3 years. The secondary patency rate was 95.92% at 1 year, 84.62% at 2 years, and 76.47% at 3 years. CONCLUSIONS: Brachial artery-transposed basilic vein arteriovenous fistula may present good primary alternative vascular access in chronic hypotensive hemodialysis patients.
机译:目的:定期进行血液透析的尿毒症患者,慢性低血压并不少见。由于频繁的血栓形成和动静脉瘘的闭塞,这部分患者通常需要进行多次手术以维持其血管通路。我们的目的是评估采用肱动脉移位的基底静脉瘘瘘的手术干预在慢性降压性血液透析患者中​​是否有效。材料与方法:本研究纳入了54例慢性低血压的血液透析患者。其中大多数是从当地医院转诊的。他们是23名男性和31名女性。在教学医院进行了为期46个月的肱肱动脉移位的基底静脉动静脉瘘。原发性通畅定义为从瘘管形成到血栓形成或需要手术切除瘘管的并发症的时间长度。二次通畅是通过是否可以通过翻修瘘管以维持血流来定义的。结果:未发生技术故障,这些患者均无因手术而死亡。 1年时的主要通畅率为89.80%,2年时为73.08%,3年时为64.710%。 1年时的二次通畅率为95.92%,2年时为84.62%,3年时为76.47%。结论:慢性低血压血液透析患者肱肱动脉移位的基底静脉动静脉瘘可能是良好的主要替代性血管通路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号